
Sign up to save your podcasts
Or
Bad trips, anti-drug PSAs, and the crackdown under the Controlled Substances Act of 1970 helped stigmatize psychedelics in the U.S. But now, there’s renewed clinical inquiry into whether these drugs can ease emotional trauma. To understand the future of psychedelics, Audie calls up Ernesto Londoño, reporter at the New York Times and author of the new book, “Trippy: The Peril and Promise of Medicinal Psychedelics.” They discuss his own mental health and psychedelic journeys and why he thinks there’s good reason for both hope and skepticism.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
4.6
903903 ratings
Bad trips, anti-drug PSAs, and the crackdown under the Controlled Substances Act of 1970 helped stigmatize psychedelics in the U.S. But now, there’s renewed clinical inquiry into whether these drugs can ease emotional trauma. To understand the future of psychedelics, Audie calls up Ernesto Londoño, reporter at the New York Times and author of the new book, “Trippy: The Peril and Promise of Medicinal Psychedelics.” They discuss his own mental health and psychedelic journeys and why he thinks there’s good reason for both hope and skepticism.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
37,996 Listeners
37,710 Listeners
1,186 Listeners
3,878 Listeners
1,695 Listeners
7,608 Listeners
25,760 Listeners
4,630 Listeners
86,402 Listeners
111,539 Listeners
2,268 Listeners
376 Listeners
303 Listeners
1,312 Listeners
140 Listeners
8,214 Listeners
334 Listeners
15,222 Listeners
123 Listeners
181 Listeners
148 Listeners
10,118 Listeners
460 Listeners
338 Listeners
1,424 Listeners
9,436 Listeners
3,154 Listeners
81 Listeners
309 Listeners
22 Listeners
1,396 Listeners
59 Listeners